Diabetic Neuropathic Pain
Conditions
Brief summary
This is a randomized controlled trial aims to evaluate the comparative effect of Pain Neuroscience Education combined with neural mobilization versus neural mobilization alone in patients with diabetic neuropathic pain. This study will Compare pain intensity between intervention groups and assess functional disability outcomes. Furthermore, this will evaluate changes in quality of life and to analyze pain-related beliefs following PNE.
Interventions
In Group A pain neuroscience Education will be given in adjunct with neural mobilization techniques Target nerves: Sciatic, tibial \& common peroneal Technique: Slider neurodynamic mobilization Dosage: 10-15 reps × 2-3 sets \| Rest: 30-60 sec between sets Session duration: 15-20 minutes PNE: 20-30 min (weeks 1-2) → 10 min reinforcement (weeks 3-6) Methods: Simple diagrams, patient-friendly metaphors, video demonstrations
Sponsors
Study design
Intervention model description
2 parallel group; Group A - PNE + Neural Mobilization and Group B - Neural Mobilization Alone
Eligibility
Inclusion criteria
Age ≥ 40 years (WHO 2016 criteria) Diagnosed Type II diabetes mellitus Lower limb neuropathic pain ≥ 3 months Pain intensity ≥ 4/10 on NPRS Able to walk independently and follow instructions
Exclusion criteria
Neurological disorders (e.g. stroke, Guillain-Barré) Lumbar disc herniation with radiculopathy Lower limb surgery or spinal fracture within 6 months Active diabetic foot ulcer Diagnosed cognitive impairment or severe infection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity | Baseline to week 6 | Pain intensity will be evaluated using Numeric Pain Rating Scale |
| Functional disability | Baseline to week 6 | Functional disability will be evaluated using Urdu version of Lower Extremity Functional Scale (LEFS) |
| Quality of life | Baseline to week 6 | Quality of life will be evaluated by World Health Organization Quality Of Life-BREF |
| Central sensitization | Baseline to week 6 | Central sensitization will be evaluated using Central Sensitization Inventory |
Countries
Pakistan